世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038852

院内感染治療薬の世界市場(2024-2028)

TechNavio

Global hospital infection therapeutics market 2024-2028

発刊日 2024/05/21

言語英語

体裁PDF/184ページ

ライセンス/価格184ページ

0000038852

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

院内感染治療薬市場は2023年から2028年に34億6,660万米ドル、予測期間中のCAGRは5.27%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、呼吸器疾患の罹患率と有病率の増加、高齢者人口の増加、特効薬指定によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 薬剤クラス別
      ◇ 抗生物質
      ◇ 抗真菌薬
      ◇ 抗ウイルス薬
    ➣ タイプ別
      ◇ 呼吸器感染症
      ◇ 手術部位感染
      ◇ 血流感染症
      ◇ 胃腸感染症
      ◇ 尿路感染症
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、今後数年間の院内感染治療薬市場成長を牽引する主要因の1つとして、病院訪問の増加を挙げています。また、新興国市場におけるアンメットニーズや病院における感染制御委員会の需要増加が、市場の大きな需要につながります。

院内感染治療薬市場に関するレポートは、次の分野をカバーしています。

  • 院内感染治療薬市場の規模
  • 院内感染治療薬市場の予測
  • 院内感染治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ Achilles Therapeutics plc
    ➣ AstraZeneca Plc
    ➣ Basilea Pharmaceutica Ltd.
    ➣ Bayer AG
    ➣ Bristol Myers Squibb Co.
    ➣ Cipla Inc.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Gilead Sciences Inc.
    ➣ GlaxoSmithKline Plc
    ➣ Johnson and Johnson Services Inc.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Pfizer Inc., Sanofi SA
    ➣ Spero Therapeutics Inc.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Hospital Infection Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Hospital Infection Therapeutics Market 2018 - 2022 ($ million)
4.2 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class
6.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
6.3 Antibiotics drugs - Market size and forecast 2023-2028
Chart on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
Chart on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
Data Table on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
6.4 Antifungal drugs - Market size and forecast 2023-2028
Chart on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
Chart on Antifungal drugs - Year-over-year growth 2023-2028 (%)
Data Table on Antifungal drugs - Year-over-year growth 2023-2028 (%)
6.5 Antiviral drugs - Market size and forecast 2023-2028
Chart on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
Chart on Antiviral drugs - Year-over-year growth 2023-2028 (%)
Data Table on Antiviral drugs - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)

7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Respiratory tract infections - Market size and forecast 2023-2028
Chart on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
Data Table on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
Chart on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
Data Table on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
7.4 Surgical site infections - Market size and forecast 2023-2028
Chart on Surgical site infections - Market size and forecast 2023-2028 ($ million)
Data Table on Surgical site infections - Market size and forecast 2023-2028 ($ million)
Chart on Surgical site infections - Year-over-year growth 2023-2028 (%)
Data Table on Surgical site infections - Year-over-year growth 2023-2028 (%)
7.5 Bloodstream infections - Market size and forecast 2023-2028
Chart on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
Data Table on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
Chart on Bloodstream infections - Year-over-year growth 2023-2028 (%)
Data Table on Bloodstream infections - Year-over-year growth 2023-2028 (%)
7.6 Gastrointestinal infections - Market size and forecast 2023-2028
Chart on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
Data Table on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
Chart on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
Data Table on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
7.7 Urinary tract infections - Market size and forecast 2023-2028
Chart on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
Data Table on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
Chart on Urinary tract infections - Year-over-year growth 2023-2028 (%)
Data Table on Urinary tract infections - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.5 Achilles Therapeutics plc
Achilles Therapeutics plc - Overview
Achilles Therapeutics plc - Product / Service
Achilles Therapeutics plc - Key offerings
12.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Hospital Infection Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Drug Class
Exhibits35: Data Table on Comparison by Drug Class
Exhibits36: Chart on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Antifungal drugs - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Antifungal drugs - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Antiviral drugs - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Antiviral drugs - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Drug Class ($ million)
Exhibits49: Data Table on Market opportunity by Drug Class ($ million)
Exhibits50: Chart on Type - Market share 2023-2028 (%)
Exhibits51: Data Table on Type - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Surgical site infections - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Surgical site infections - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Surgical site infections - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Surgical site infections - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Bloodstream infections - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Bloodstream infections - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
Exhibits71: Data Table on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
Exhibits72: Chart on Urinary tract infections - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Urinary tract infections - Year-over-year growth 2023-2028 (%)
Exhibits74: Market opportunity by Type ($ million)
Exhibits75: Data Table on Market opportunity by Type ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits78: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits115: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits117: Market opportunity By Geographical Landscape($ million)
Exhibits118: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits119: Impact of drivers and challenges in 2023 and 2028
Exhibits120: Overview on criticality of inputs and factors of differentiation
Exhibits121: Overview on factors of disruption
Exhibits122: Impact of key risks on business
Exhibits123: Companies covered
Exhibits124: Matrix on companies position and classification
Exhibits125: Abbott Laboratories - Overview
Exhibits126: Abbott Laboratories - Business segments
Exhibits127: Abbott Laboratories - Key news
Exhibits128: Abbott Laboratories - Key offerings
Exhibits129: Abbott Laboratories - Segment focus
Exhibits130: AbbVie Inc. - Overview
Exhibits131: AbbVie Inc. - Product / Service
Exhibits132: AbbVie Inc. - Key news
Exhibits133: AbbVie Inc. - Key offerings
Exhibits134: Achilles Therapeutics plc - Overview
Exhibits135: Achilles Therapeutics plc - Product / Service
Exhibits136: Achilles Therapeutics plc - Key offerings
Exhibits137: AstraZeneca Plc - Overview
Exhibits138: AstraZeneca Plc - Product / Service
Exhibits139: AstraZeneca Plc - Key news
Exhibits140: AstraZeneca Plc - Key offerings
Exhibits141: Bayer AG - Overview
Exhibits142: Bayer AG - Business segments
Exhibits143: Bayer AG - Key news
Exhibits144: Bayer AG - Key offerings
Exhibits145: Bayer AG - Segment focus
Exhibits146: Bristol Myers Squibb Co. - Overview
Exhibits147: Bristol Myers Squibb Co. - Product / Service
Exhibits148: Bristol Myers Squibb Co. - Key news
Exhibits149: Bristol Myers Squibb Co. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: Gilead Sciences Inc. - Overview
Exhibits156: Gilead Sciences Inc. - Product / Service
Exhibits157: Gilead Sciences Inc. - Key news
Exhibits158: Gilead Sciences Inc. - Key offerings
Exhibits159: GlaxoSmithKline Plc - Overview
Exhibits160: GlaxoSmithKline Plc - Business segments
Exhibits161: GlaxoSmithKline Plc - Key news
Exhibits162: GlaxoSmithKline Plc - Key offerings
Exhibits163: GlaxoSmithKline Plc - Segment focus
Exhibits164: Johnson and Johnson Services Inc. - Overview
Exhibits165: Johnson and Johnson Services Inc. - Business segments
Exhibits166: Johnson and Johnson Services Inc. - Key news
Exhibits167: Johnson and Johnson Services Inc. - Key offerings
Exhibits168: Johnson and Johnson Services Inc. - Segment focus
Exhibits169: Merck and Co. Inc. - Overview
Exhibits170: Merck and Co. Inc. - Business segments
Exhibits171: Merck and Co. Inc. - Key news
Exhibits172: Merck and Co. Inc. - Key offerings
Exhibits173: Merck and Co. Inc. - Segment focus
Exhibits174: Novartis AG - Overview
Exhibits175: Novartis AG - Business segments
Exhibits176: Novartis AG - Key news
Exhibits177: Novartis AG - Key offerings
Exhibits178: Novartis AG - Segment focus
Exhibits179: Pfizer Inc. - Overview
Exhibits180: Pfizer Inc. - Product / Service
Exhibits181: Pfizer Inc. - Key news
Exhibits182: Pfizer Inc. - Key offerings
Exhibits183: Sanofi SA - Overview
Exhibits184: Sanofi SA - Business segments
Exhibits185: Sanofi SA - Key news
Exhibits186: Sanofi SA - Key offerings
Exhibits187: Sanofi SA - Segment focus
Exhibits188: Viatris Inc. - Overview
Exhibits189: Viatris Inc. - Business segments
Exhibits190: Viatris Inc. - Key news
Exhibits191: Viatris Inc. - Key offerings
Exhibits192: Viatris Inc. - Segment focus
Exhibits193: Inclusions checklist
Exhibits194: Exclusions checklist
Exhibits195: Currency conversion rates for US$
Exhibits196: Research methodology
Exhibits197: Information sources
Exhibits198: Data validation
Exhibits199: Validation techniques employed for market sizing
Exhibits200: Data synthesis
Exhibits201: 360 degree market analysis
Exhibits202: List of abbreviations

この商品のレポートナンバー

0000038852

TOP